RxDoctor Payments Data

Debra Klinger

Family · Vicksburg, MINPI 1346607447

Payments from drug & device makers

$737in general payments, 2019–2025

Across 40 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$169
  • Lilly USA, LLC$160
  • AbbVie$82
  • AstraZeneca$72
  • Boehringer Ingelheim$42
  • Abbott$37
  • plus $174 from 8 others

What the payments were for

  • Food & beverage$737100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$737 in reported general payments places this provider in the 65th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$26,950
Medicare patients
155
Services billed
358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin82$77,835
EliquisApixaban28$36,025
TrulicityDulaglutide25$32,877
OzempicSemaglutide24$25,668
MounjaroTirzepatide21$20,902
XareltoRivaroxaban12$19,416
Advair HfaFluticasone Propion/Salmeterol17$6,508
Fluticasone-SalmeterolFluticasone Propion/Salmeterol30$6,007
Atorvastatin Calcium369$4,992
Duloxetine Hcl64$4,975
Breo ElliptaFluticasone/Vilanterol11$4,378
Levothyroxine Sodium315$3,928
Omeprazole260$3,829
Rosuvastatin Calcium240$3,530
Famotidine92$3,518

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$42$77,83582 claims
Lilly USA, LLCTrulicity, Mounjaro$160$53,77946 claims
PfizerEliquis$28$36,02528 claims
Novo NordiskOzempic$169$25,66824 claims
Johnson & JohnsonXarelto$17$19,41612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,657 family providers in Michigan.

Other family in Vicksburg

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →